IGM Biosciences IGMS
$ 8.78
-10.11%
Quarterly report 2024-Q3
added 11-08-2024
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Fred Schwarzer |
Employees in the company |
103 |
Shares |
52.3 M |
Market Cap[1] |
$ 459 M |
EBITDA (LTM) |
$ -226 M |
P/E (LTM) |
-3.44 |
P/S (LTM) |
- |
EPS (LTM) |
-3.67 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.